Emicizumab

Emicizumab is a prescription medication used to prevent bleeding in people with hemophilia A, a genetic disorder where blood doesn't clot properly. It works as a synthetic protein that mimics the function of a missing clotting factor, bridging specific blood components to help form a clot and stop bleeding. Administered as a weekly or bi-weekly injection, emicizumab provides a flexible and long-lasting alternative to traditional treatments, reducing the frequency of infusions and improving quality of life for patients managing hemophilia A.